{
    "organizations": [],
    "uuid": "dace69047e268e5c41665f12f6239dd6fa50b011",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sangamo-therapeutics-proposes-publ/brief-sangamo-therapeutics-proposes-public-offering-of-common-stock-idUSASC09X4A",
    "ord_in_thread": 0,
    "title": "BRIEF-Sangamo Therapeutics Proposes Public Offering Of Common Stock",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " Sangamo Therapeutics Inc:\n* SANGAMO THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK\n* SANGAMO THERAPEUTICS INC - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING OF $200.0 MILLION OF SHARES OF ITS COMMON STOCK\n* SANGAMO THERAPEUTICS - SEES USING NET PROCEEDS FROM OFFERING TO SUPPORT OWN, PARTNERED GENE THERAPY, GENOME EDITING, CELL THERAPY, AMONG OTHER THINGS Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-25T04:22:00.000+03:00",
    "crawled": "2018-04-25T14:13:27.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "sangamo",
        "therapeutic",
        "inc",
        "sangamo",
        "therapeutic",
        "announces",
        "proposed",
        "public",
        "offering",
        "common",
        "stock",
        "sangamo",
        "therapeutic",
        "inc",
        "commenced",
        "underwritten",
        "public",
        "offering",
        "million",
        "share",
        "common",
        "stock",
        "sangamo",
        "therapeutic",
        "see",
        "using",
        "net",
        "proceeds",
        "offering",
        "support",
        "partnered",
        "gene",
        "therapy",
        "genome",
        "editing",
        "cell",
        "therapy",
        "among",
        "thing",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}